Common diabetes drug tested to fight mouth scarring

NCT ID NCT06871904

Summary

This study tested whether two existing drugs, metformin (a diabetes medication) and pirfenidone (an anti-scarring drug), could help treat oral submucous fibrosis—a chronic condition that causes scarring in the mouth and can limit mouth opening. Researchers first tested the drugs on cells in a lab to understand how they work, then conducted a small clinical trial with 45 patients to see if the treatments improved symptoms. The goal was to find a more affordable and effective way to control this progressive condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL SUBMUCOUS FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ziauddin University

    Karachi, Sindh, 74700, Pakistan

Conditions

Explore the condition pages connected to this study.